Expanding the Conversation Around Radiotherapy for Lentigo Maligna, Response to Radiotherapy versus Imiquimod for Complex Lentigo Maligna: A Phase 3 Randomized Clinical Trial

Authors

Jessica Houpe, HCA HealthcareFollow
Austinn Miller, HCA HealthcareFollow
Genevieve Patrick, HCA HealthcareFollow
Amir Aboutalebi
Harris Green
Armand B. Cognetta, HCA HealthcareFollow

Division

North Florida

Hospital

Capital Regional Medical Center

Document Type

Letter to the Editor

Publication Date

2-23-2026

Keywords

alternative therapy, dermatology, grenz ray, imiquimod, lentigo maligna, mohs, radiotherapy

Disciplines

Dermatology | Medicine and Health Sciences | Neoplasms | Skin and Connective Tissue Diseases

Abstract

No abstract available.

Publisher or Conference

Journal of the American Academy of Dermatology

Recommended Citation

Houpe J, Miller A, Patrick G, Aboutalebi A, Green H, Cognetta AB Jr. Expanding the conversation around radiotherapy for lentigo maligna, response to Radiotherapy versus imiquimod for complex lentigo maligna: A phase 3 randomized clinical trial. J Am Acad Dermatol. Published online February 23, 2026. doi:10.1016/j.jaad.2025.12.125